Influenza Vaccines Market Analysis: Projected Growth to $10.1 Billion by 2028 Driven by Increased Immunization Rates, Emerging Trends, and Robust Demand Forecast

The new report published by The Business Research Company, titled Influenza Vaccines Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the influenza vaccines market size has grown strongly in recent years. It will grow from $6.91 billion in 2023 to $7.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The influenza vaccines market size is expected to see strong growth in the next few years. It will grow to $10.1 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

The Rising Incidences Of Seasonal Influenza Drive Growth In The Influenza Vaccine Market
The rising incidences of seasonal influenza are expected to propel the growth of the influenza vaccine market going forward. Seasonal influenza refers to a respiratory illness caused by influenza viruses that typically circulate and cause infections during specific times of the year, usually in the colder months. This shift has resulted from antigenic drift, population susceptibility, environmental factors, incomplete vaccine coverage, and lack of universal vaccination. Influenza vaccines help in reducing the incidences of seasonal influenza by providing immunization against the circulating strains of the virus. For instance, in October 2022, according to Central Drugs Standard Control Organization, an India-based national regulatory body for cosmetics and pharmaceuticals, the overall burden of influenza for 2021-2022 is estimated as nine million flu illnesses, 100,000 flu-related hospitalizations, 4 million flu-related medical visits, and 5,000 flu deaths. Therefore, the rising incidences of seasons of influenza are driving the growth of the influenza vaccines market.

Adoption Of Technologically Advanced Vaccine Production Drives Growth In The Influenza Vaccine Market
Technologically advanced vaccine production is a key trend gaining popularity in the influenza vaccine market. Companies operating in the influenza vaccine market are adopting advanced vaccine production technologies to sustain their position in the market. For instance, in January 2023, GlaxoSmithKline PLC., a UK-based pharmaceutical and biotechnology company introduced MAPS - Multiple Antigen Presenting System for vaccine development. This technology is providing an innovative way to develop effective vaccines to fight bacteria and viruses. This technology is useful for developing vaccines in a short period in case outbreak of an epidemic or pandemic.

The influenza vaccines market covered in this report is segmented -

1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=11935&type=discount

Major companies operating in the influenza vaccines market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Contents of the report:
1. Executive Summary
2. Influenza Vaccines Market Report Structure
3. Influenza Vaccines Market Trends And Strategies
4. Influenza Vaccines Market - Macro Economic Scenario
5. Influenza Vaccines Market Size And Growth
…..
27. Influenza Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.